SOPHiA GENETICS reported a 25% year-over-year revenue increase to $24.3 million in Q3 2026, driven by strong U.S. market growth and BioPharma partnerships. Adjusted EBITDA loss improved by 31% to $6.1 million, reflecting operational efficiencies and progress toward profitability. The company expects full-year 2026 revenue at the high end of $94-96 million guidance, though foreign exchange rates pose a potential challenge for Q4. New customer acquisitions and expanded BioPharma collaborations position SOPHiA GENETICS for continued growth in 2027.
SOPHiA GENETICS' third quarter 2026 results provide context for readers interested in health-sector stocks. For readers following health-sector US stocks on Pluang, here is the market snapshot as of Nov 03, 2026 17:51 WIB: out of 150 priced stocks, 70 rose and 69 fell. Notable movers include RVTY (Revvity Inc) at USD 145.01 with a 1-day change of -4.38% and a typical hold time of 13 days, TVTX (Travere Therapeutics Inc.) at USD 47.30 down 3.98% with a 19-day hold time, and NUWE (Nuwellis Inc) at USD 5.01 down 3.28%, with Pluang order activity showing 45% sell and 55% buy, and a 30-day typical hold time.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
